Paul Sanfilippo

9PUBLICATIONS
96CO-AUTHORS
Neurology and neuromuscular diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Human impacts of climate change and human adaptationInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 05, 2026
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.

Pakeeran Siriratnam, Vilija G Jokubaitis, Anneke Van Der Walt

|Jun 19, 2025
Acute and Long-Term Immune-Treatment Strategies in Anti-LGI1 Antibody-Mediated Encephalitis: A Multicenter Cohort Study.

Nabil Seery, Robb Wesselingh, Paul Beech

|May 30, 2025
Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study.

Nabil Seery, Robb Wesselingh, Paul Beech

|Nov 19, 2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD.

Pakeeran Siriratnam, Saif Huda, Anneke Van Der Walt

|Feb 24, 2024
Myopia progression following 0.01% atropine cessation in Australian children: Findings from the Western Australia - Atropine for the Treatment of Myopia (WA-ATOM) study.

Samantha Sze-Yee Lee, Vinay Kumar Nilagiri, Gareth Lingham

|Sep 02, 2022
Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: A randomised clinical trial.

Samantha Sze-Yee Lee, Gareth Lingham, Magdalena Blaszkowska

Pageof 2

Frequent Collaborators

4 joint publications

David A Mackey

4 joint publications

Tomas Kalincik

4 joint publications

Anneke Van Der Walt

4 joint publications

Helmut Butzkueven